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S U M M A R Y
Objectives: To examine whether there is any association between serum levels of 25-hydroxy vitamin D
(25(OH) vitamin D) and the recurrence of urinary tract infections (UTIs) among premenopausal women.
Methods: During a period of 3 years, 93 premenopausal women with a medical history of recurrent UTIs
were enrolled from the Infectious Diseases Unit. Cases with recurrent UTIs were compared to 93 age-
matched (5 years) women with no history of recurrent UTI (control group), in terms of serum 25(OH)
vitamin D and different risk factors for recurrent UTI. Recurrent UTI was deﬁned as three or more episodes of
UTI over a 12-month period.
Results: The mean age of women with recurrent UTIs was 43.8  9 years and of controls was 39  10 years
(p = 0.839). The mean serum levels of 25(OH) vitamin D among women with recurrent UTIs were
signiﬁcantly lower than those of controls (9.8 ng/ml  4 vs. 23 ng/ml  6; p < 0.001). Multivariate analysis
showed that a serum 25(OH) vitamin D level of < 15 ng/ml (odds ratio 4.00, 95% conﬁdence interval 3.40–
4.62; p = 0.001) was associated with recurrent UTIs in premenopausal women.
Conclusions: In this retrospective study, we found that recurrent UTIs in premenopausal women are
associated with vitamin D deﬁciency.
 2013 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
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jou r nal h o mep ag e: w ww .e lsev ier . co m / loc ate / i j id1. Introduction
Urinary tract infection (UTI) is one of the most commonly
acquired bacterial infections in ambulatory and hospitalized
populations. Approximately 11% of all women aged 18 years in
the USA have a UTI each year. The incidence of UTI is highest
among women aged 18–24 years, approaching one of ﬁve
infections per year.1 The incidence of UTIs in Israel is not so well
known, as there is a lack of epidemiological studies on this topic.
Although, the risk of bladder UTI (cystitis) progression to
pyelonephritis is negligible among otherwise healthy women,
cystitis has a propensity to recur. Among healthy women aged 18–
39 years, the 6-month risk of recurrence following a ﬁrst UTI is
24%.2 Approximately 5% of women with an initial UTI have
multiple episodes within a year. Major risk factors for UTI among
women aged 18–39 years are engaging in sexual intercourse and
having a history of UTI.* Corresponding author. Tel.: +972 747559050; fax: +972 747559051.
E-mail address: w.nseir@yahoo.com (W. Nseir).
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http://dx.doi.org/10.1016/j.ijid.2013.06.007Treating UTIs with antibiotics selects for antibiotic resistance
among uropathogens and other bacteria found in and on the
human body. In the USA, and worldwide, uropathogens are
increasingly resistant to antibiotics.3–7 Women with recurrent
UTIs are prescribed repeated courses of antibiotics both as
treatment and as a preventive strategy. Because antibiotic therapy
is a major driver of resistance and adversely affects the normal
microbiota, preventive strategies that reduce the need for
antibiotic therapy are particularly important.
Vitamin D deﬁciency has been associated with several adverse
health consequences, including autoimmune diseases and infec-
tions.8–10 The results of epidemiological studies have demonstrat-
ed the existence of a link between vitamin D deﬁciency and the
increased occurrence of pulmonary tuberculosis and respiratory
infections.11,12 Recently we showed an association between low
serum levels of 25-hydroxy vitamin D (25(OH) vitamin D) and the
risk of recurrent bacterial infections.13–15
Against this background, we conducted this retrospective study
in order to examine whether there is any association between the
serum levels of 25(OH) vitamin D and the risk of recurrent UTIs in
premenopausal women.ses. Published by Elsevier Ltd. All rights reserved.
W. Nseir et al. / International Journal of Infectious Diseases 17 (2013) e1121–e1124e11222. Materials and methods
2.1. Subjects
We included all premenopausal women with recurrent UTIs
who were followed-up between 2009 and 2011 at the Infectious
Diseases Unit of EMMS, a 170-bed primary care hospital in
Nazareth, Israel. Premenopausal women aged 20–52 years who
had not received antibiotic prophylaxis for recurrent UTIs,
including post-coital, were included. The exclusion criteria were:
(1) pregnancy, and (2) chronic renal failure (creatinine clearance
test <30 ml/min), a chronic liver disease, a malignancy with life
expectancy less than 1 year, HIV infection, connective tissue
diseases, permanent urinary catheter, urinary tract stent, neph-
rostomy tube, urinary incontinence, neurogenic bladder, asymp-
tomatic bacteriuria, kidney malformations, kidney stones,
gynecological problems, organ transplant, chronic use of cortico-
steroid therapy, vitamin D supplementation, and substance abuse.
Control cases were premenopausal women with no medical
history of UTI, randomly collected from the Medicine Clinic and
Employee Health Clinic, EMMS, who were age-matched 5 years;
the same exclusion criteria were used. The matching was performed
on a group, rather than individual level. For each case of recurrent UTI
we recruited one control case. The study was approved by the review
board of EMMS.
2.2. Study design
This was a retrospective study aimed at examining the
association between serum 25(OH) vitamin D levels and recurrent
UTIs in premenopausal women. In order to assess this, we
compared the two groups of premenopausal women – with and
without recurrent UTIs – in term of: diabetes mellitus (DM),
maternal history of recurrent UTIs, oral contraceptive use,
probiotics, cranberry juice consumption, sexual intercourse, and
serum levels of 25(OH) vitamin D.
2.3. Clinical and laboratory data
Information concerning medical conditions and drug therapy,
and the results of laboratory analyses, were extracted from the
medical charts of each subject in the two groups. (In general, every
subject who visits the Infectious Diseases Unit/Medicine Clinic/the
Employee Health Clinic, completes a standard questionnaire at
every visit concerning their medical condition, drug therapy,
family history of different diseases, systemic bacterial infections,
and results of laboratory analyses, including urinalysis and urine
culture.) The results of chemistry analysis, including fasting blood
glucose, hemoglobin A1c (HbA1c), serum creatinine, serum
calcium, and a complete blood count, were collected from the
medical charts. Serum 25(OH) vitamin D levels were measured in
winter and summer seasons (at least twice a year) for all patients
visiting our units. Serum 25(OH) vitamin D levels were measuredTable 1
A comparison of certain clinical and laboratory parameters between cases with recurr
Cases with recu
(n = 93)
Age, years, mean  SD 43.8  9 
Diabetes mellitus, n (%) 26 (28%) 
Maternal history of recurrent UTI, n (%) 13 (14%) 
Use of oral contraceptives, n (%) 2 (2.2%) 
Use of probiotics, n (%) 2 (2.2%) 
Sexual intercourse 1 per week (%), n (%) 45 (48%) 
Serum 25(OH) vitamin D, ng/ml, mean  SD 9.8  4 
Indoor, n (%) 82 (88%) 
UTI, urinary tract infection; SD, standard deviation; NS, not signiﬁcant.using a commercial kit (IMM, Bensheim, Germany), by enzyme
immunoassay (EIA). The normal range of serum 25(OH) vitamin D
levels is 30–50 ng/ml.
2.4. Deﬁnitions
UTI was deﬁned by clinical signs of dysuria and the urgency and
frequency of urination (cystitis), and the presence of fever, chills,
and/or loin pain (pyelonephritis). Bacterial UTIs included cystitis,
urethritis, and acute pyelonephritis.16 Recurrent UTI was deﬁned
as a symptomatic UTI following the resolution of a previous UTI
and of three or more symptomatic episodes over a 12-month
period.17 All case patients had to have recurrent UTIs including one
or more culture-conﬁrmed UTI; the UTI could be a case of re-
infection or relapse. Re-infection refers to a new infection, i.e. the
urine shows no growth after the previous infection, but the same
organism grows again at 2 weeks after treatment, or a different
strain is grown at any time. A relapse refers to a UTI caused by the
bacterial strain from a focus inside the urinary tract within 2 weeks
of treatment. Normal levels of serum creatinine are 0.67–1.17 mg/
dl and of serum calcium are 8.1–10.4 mg/dl. We deﬁned vitamin D
insufﬁciency as levels of 25(OH) vitamin D 20–30 ng/ml, and
vitamin D deﬁciency as levels of 25(OH) vitamin D <20 ng/ml.
2.5. Statistical analysis
WinSTAT (Kalamia, Cambridge, MA, USA) was used for data
handling and analysis. Mean values, standard deviations (SDs), and
p-values were calculated. The Chi-square test was performed for
categorical variables, and the Student’s t-test was used for
continuous variables. Spearman rank correlation and univariate
regression analysis were used to determine the strengths of the
relationships between the different risk factors and recurrent UTIs.
A risk factor associated with a p-value of <0.05 in the univariate
analysis was used for further analysis. A multivariate analysis was
performed to determine the association between the risk factors
and recurrent UTIs. Statistical signiﬁcance was set at 5%.
3. Results
Of 265 women followed-up in the Infectious Diseases Unit for
UTIs during the study period, 93 premenopausal women with
recurrent UTIs met the inclusion criteria. One hundred and
seventy-two subjects were excluded because of: postmenopausal
(n = 41), no recurrent UTI (n = 60), pregnancy (n = 7), chronic renal
failure (n = 19), liver cirrhosis (n = 7), malignancy with life
expectancy <1 year (n = 16), permanent urinary catheter (n = 7),
kidney stones (n = 5), chronic steroid use (n = 3), and vitamin D use
(n = 7). Table 1 shows the clinical and laboratory parameters of the
cases with recurrent UTIs and the controls. No signiﬁcant
difference was found between the cases and controls in terms of
age, DM, maternal history of recurrent UTIs, oral contraceptive use,
probiotics, sexual intercourse, and indoor/outdoor activities. Noent UTIs and controls
rrent UTI Controls
(n = 93)
p-Value
39  10 NS
20 (21.5%) NS
6 (6.5%) NS
4 (4.3%) NS
6 (6.5%) NS
54 (58%) NS
23  6 <0.001
78 (84%) NS
W. Nseir et al. / International Journal of Infectious Diseases 17 (2013) e1121–e1124 e1123subjects in the two study groups were using cranberry juice as
prophylaxis. However, compared to the control group, serum
25(OH) vitamin D levels were signiﬁcantly lower in the cases (9.8
ng/ml  4 vs. 23 ng/ml  6, respectively; p < 0.001). The lowest
25(OH) vitamin D level was 4 ng/ml, which was found in one subject
who suffered from recurrent UTIs (at least 6 episodes/year); the
highest level was 46 ng/ml, which was found in one subject in the
control group. All study participants were of the same race.
Multivariate analysis showed that a maternal history of
recurrent UTIs (odds ratio (OR) 1.60, 95% conﬁdence interval
(CI) 1.40–2.60; p = 0.05), no use of probiotics (OR 1.94, 95% CI 1.61–
2.82; p = 0.04), and serum 25(OH) vitamin D <15 ng/ml (OR 4.00,
95% CI 3.40–4.62; p = 0.001), were associated with recurrent UTIs
in premenopausal women. The multivariate analysis results are
shown in Table 2.
4. Discussion
In this retrospective study, we found that vitamin D deﬁciency
in premenopausal women was independently associated with
recurrent UTIs.
The mechanism(s) that link vitamin D deﬁciency with recurrent
UTI are unknown. There are many host defense factors in the
urinary tract, such as the Tamm–Horsfall protein, lipocalin, and
lactoferrin, which offer some protection from infection.18 Infec-
tions of the urinary tract induce epithelial cells to produce
cathelicidin LL-37, protecting against bacterial infection.19 Vitamin
D is a potent stimulator of antimicrobial peptides including
cathelicidin LL-37 in innate immunity.20 Recently, Hertting et al.
observed a signiﬁcant increase in cathelicidin in response to
vitamin D in biopsy samples of urinary bladder infected by
uropathogenic Escherichia coli.21 In humans, the production of
cathelicidin and some defensins depends upon vitamin D levels,
particularly during the infection process.22 Previous studies have
shown the importance of vitamin D for innate immunity in
defending against bacterial infections, mainly by increasing the
neutrophilic motility and phagocytic function.23,24 We consider
that these abovementioned mechanisms could explain why
women with low levels of serum 25(OH) vitamin D are prone to
recurrent UTIs. However, more studies are needed to investigate
the mechanisms involved in the pathogenesis of vitamin D
deﬁciency and predisposition to bacterial infections.
In case–control studies, Scholes et al.25 and Hooten26 reported
that a history of UTI in the mother is associated with 2–3-fold
increase in risk of UTI in her daughters. A maternal history of UTI
suggests that inherited factors may be important in some cases of
recurrent UTI.27 Otherwise, this risk factor could reﬂect other
shared environmental factors, or behaviors present in both
mothers and daughters. The contribution of genetics to UTIs has
been discussed in several studies.28,29 Lundstedt et al. showed that
susceptibility to acute pyelonephritis is inherited and that low
CXCR1 expression might predispose to acute pyelonephritis.29 In
our study we found that a maternal history of UTI was associated
with 1.6-fold increase in the risk of recurrent UTI.Table 2
Results of the multivariate analysis of recurrent UTI among premenopausal women
Variable OR (95% CI) p-Value
Age >35 years 1.55 (1.10–2.82) NS
Maternal history of recurrent UTI 1.60 (1.40–2.60) 0.05
No use of probiotics 1.94 (1.61–2.82) 0.04
25(OH) vitamin D of <15 ng/ml 4.0 (3.40–4.62) 0.001
Sexual intercourse 1 per week 1.25 (0.75–2.2) NS
UTI, urinary tract infection; OR, odds ratio; CI, conﬁdence interval; NS, not
signiﬁcant.Lactobacilli are the dominant bacteria of the vaginal ﬂora and
possess antimicrobial properties that regulate the urogenital
microbiota. Incomplete cure and recurrence of genitourinary
infections leads to a shift in the local ﬂora from a predominance of
lactobacilli to coliform uropathogens. The use of Lactobacillus-
containing probiotics to restore the commensal vaginal ﬂora has
been proposed for the treatment and prophylaxis of recurrent
UTIs.30 Recently, a meta-analysis was done regarding Lactobacillus
for the prevention of UTIs in women.31 Data from 127 patients in
two studies were included. Results showed probiotic strains of
Lactobacillus to be safe and effective in preventing recurrent UTIs
in adult women. In our study we found no use of probiotics to be
associated with recurrent UTIs in premenopausal women.
However, more randomized clinical trials (RCTs) are needed to
examine the efﬁcacy of probiotics as prophylaxis in recurrent UTIs.
Our study has several limitations: being a retrospective study,
including a relatively small number of subjects, having incomplete
data concerning body mass index, and not investigating the role of
vitamin D receptors, cathelicidin, and the innate immune system.
In conclusion, vitamin D deﬁciency was found to be associated
with recurrent UTIs in premenopausal women. RCTs are needed to
assess if a correction of serum levels of 25(OH) vitamin D could
prevent the recurrence of UTIs.
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